Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LGALS8 | O00214 | 1/20 | 0.57 |
| ▸ | LGALS3 | P17931 | 1/20 | 0.57 |
| ▸ | LGALS4 | P56470 | 1/20 | 0.57 |
| ▸ | MEN1 | O00255 | 2/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.51 |
| ▸ | AMY2A | P04746 | 2/20 | 0.51 |
| ▸ | ENGASE | Q8NFI3 | 1/20 | 0.50 |
| ▸ | CD209 | Q9NNX6 | 1/20 | 0.50 |
| ▸ | FGF1 | P05230 | 1/20 | 0.47 |
| ▸ | FGF2 | P09038 | 1/20 | 0.47 |
| ▸ | VEGFA | P15692 | 1/20 | 0.47 |
| ▸ | HPSE | Q9Y251 | 1/20 | 0.47 |
| ▸ | TYR | P14679 | 2/20 | 0.47 |
| ▸ | AMY1A | P0DUB6 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 2/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.46 |
| ▸ | GJA1 | P17302 | 1/20 | 0.46 |
| ▸ | GJB2 | P29033 | 1/20 | 0.46 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31614391 | 1.00 | LGALS8 (0.57) | LGALS8LGALS3LGALS4MEN1KMT2A | |
| SCHEMBL31701579 | 1.00 | LGALS8 (0.57) | LGALS8LGALS3LGALS4MEN1KMT2A | |
| SCHEMBL31700326 | 1.00 | LGALS8 (0.57) | LGALS8LGALS3LGALS4MEN1KMT2A | |
| SCHEMBL31700334 | 1.00 | LGALS8 (0.57) | LGALS8LGALS3LGALS4MEN1KMT2A | |
| SCHEMBL31614389 | 1.00 | LGALS8 (0.57) | LGALS8LGALS3LGALS4MEN1KMT2A | |
| SCHEMBL295024 | 1.00 | LGALS8 (0.57) | LGALS8LGALS3LGALS4MEN1KMT2A | |
| SCHEMBL3149886 | 1.00 | LGALS8 (0.57) | LGALS8LGALS3LGALS4MEN1KMT2A | |
| SCHEMBL31614393 | 1.00 | LGALS8 (0.57) | LGALS8LGALS3LGALS4MEN1KMT2A | |
| SCHEMBL21243223 | 1.00 | LGALS8 (0.57) | LGALS8LGALS3LGALS4MEN1KMT2A | |
| SCHEMBL31700630 | 1.00 | LGALS8 (0.57) | LGALS8LGALS3LGALS4MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 116 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040121431-A1 | used for formation of cyclotetrasaccharide from a saccharide with a glucose polymerization degree of 3 or higher; genetic engineering | KABUSHIKI KAISHA HAYASHIBARA SEIBUTSU KAGAKU KENKYUJO (JP) | 2004-06-24 | — | — | US | claimed |
| EP-1335020-A1 | POLYPEPTIDES HAVING ALPHA-ISOMALTOSYL TRANSFERASE ACTIVITY | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo (JP) | 2003-08-13 | — | — | EP | claimed |
| JP-63046201-A | — | — | None | — | — | JP | disclosed |
| CN-113549606-B | Alpha-amylase variants with altered properties | 诺维信公司 | 2024-07-16 | — | — | CN | disclosed |
| US-20240218340-A1 | Enzyme Variants and Polynucleotides Encoding Same | NOVOZYMES A/S (DK) | 2024-07-04 | — | — | US | disclosed |
| US-20240093170-A1 | Enzyme Variants and Polynucleotides Encoding the Same | NOVOZYMES A/S (DK) | 2024-03-21 | — | — | US | disclosed |
| US-11859221-B2 | Enzyme variants and polynucleotides encoding the same | NOVOZYMES A/S (DK) | 2024-01-02 | — | — | US | disclosed |
| EP-4269684-A2 | ALPHA-AMYLASE VARIANTS WITH ALTERED PROPERTIES | Novozymes A/S (DK) | 2023-11-01 | — | — | EP | disclosed |
| EP-4219702-A2 | ENZYME VARIANTS AND POLYNUCLEOTIDES ENCODING THE SAME | Novozymes A/S (DK) | 2023-08-02 | — | — | EP | disclosed |
| CN-109312319-B | Variant polypeptides with improved properties and uses thereof | 诺维信公司 | 2023-05-16 | — | — | CN | disclosed |
| US-11248193-B2 | Stabilized alpha-amylase variants and use of the same | NOVOZYMES A/S (DK) | 2022-02-15 | — | — | US | disclosed |
| EP-1361274-A1 | POLYPEPTIDE HAVING ALPHA-ISOMALTOSYLGLUCOSACCHARIDE SYNTHASE ACTIVITY | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo (JP) | 2003-11-12 | — | — | EP | disclosed |
| EP-1360988-A1 | DEHYDRATING AGENT AND METHOD FOR DEHYDRATING MOIST ARTICLE USING THE AGENT AND DEHYDRATED ARTICLE OBTAINED BY THE METHOD | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo (JP) | 2003-11-12 | — | — | EP | disclosed |
| US-20030194762-A1 | Alpha-Isomaltosylglucosaccharide synthase, process for producing the same and use thereof | KABUSHIKI KAISHA HAYASHIBARA SEIBUTSU KAGAKU KENKYUJO (JP) | 2003-10-16 | — | — | US | disclosed |
| EP-1335020-A1 | POLYPEPTIDES HAVING ALPHA-ISOMALTOSYL TRANSFERASE ACTIVITY | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo (JP) | 2003-08-13 | — | — | EP | disclosed |
| EP-1326965-A2 | ALPHA-AMYLASE VARIANT WITH ALTERED PROPERTIES | Novozymes A/S (DK) | 2003-07-16 | — | — | EP | disclosed |
| WO-2002092797-A2 | ALPHA-AMYLASE VARIANT WITH ALTERED PROPERTIES | NOVOZYMES A/S (DK) | 2002-11-21 | — | — | WO | disclosed |
| EP-1229112-A1 | ALPHA-ISOMALTOSYLGLUCOSACCHARIDE SYNTHASE, PROCESS FOR PRODUCING THE SAME AND USE THEREOF | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo (JP) | 2002-08-07 | — | — | EP | disclosed |
| WO-2002031124-A2 | ALPHA-AMYLASE VARIANT WITH ALTERED PROPERTIES | NOVOZYMES A/S (DK) | 2002-04-18 | — | — | WO | disclosed |
| JP-S6346201-A | MULTIPLY BRANCHED CYCLODEXTRIN AND ITS PRODUCTION | NATL FOOD RES INST | 1988-02-27 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040121431-A1 | used for formation of cyclotetrasaccharide from a saccharide with a glucose polymerization degree of 3 or higher; genetic engineering | UGGT1, IDUA, GALE | LGALS8 1327/4885LGALS3 1725/4885LGALS4 1410/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.